vs
Side-by-side financial comparison of Solventum (SOLV) and VALMONT INDUSTRIES INC (VMI). Click either name above to swap in a different company.
Solventum is the larger business by last-quarter revenue ($2.0B vs $1.0B, roughly 1.9× VALMONT INDUSTRIES INC). VALMONT INDUSTRIES INC runs the higher net margin — 16.2% vs 0.6%, a 15.5% gap on every dollar of revenue. On growth, VALMONT INDUSTRIES INC posted the faster year-over-year revenue change (0.1% vs -3.0%). VALMONT INDUSTRIES INC produced more free cash flow last quarter ($70.4M vs $-273.0M). Over the past eight quarters, VALMONT INDUSTRIES INC's revenue compounded faster (3.0% CAGR vs -1.8%).
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
Valmont Industries, Inc. is a large, publicly held American manufacturer of Valley center pivot and linear irrigation equipment, windmill support structures, lighting and traffic poles and steel utility poles.
SOLV vs VMI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.0B |
| Net Profit | $13.0M | $168.0M |
| Gross Margin | 54.7% | 29.8% |
| Operating Margin | 4.0% | 11.2% |
| Net Margin | 0.6% | 16.2% |
| Revenue YoY | -3.0% | 0.1% |
| Net Profit YoY | — | 116.3% |
| EPS (diluted) | $0.07 | $9.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $1.0B | ||
| Q3 25 | $2.1B | $1.0B | ||
| Q2 25 | $2.2B | $1.1B | ||
| Q1 25 | $2.1B | $969.3M | ||
| Q4 24 | $2.1B | $1.0B | ||
| Q3 24 | $2.1B | $1.0B | ||
| Q2 24 | $2.1B | $1.0B |
| Q1 26 | $13.0M | — | ||
| Q4 25 | $63.0M | $168.0M | ||
| Q3 25 | $1.3B | $99.0M | ||
| Q2 25 | $90.0M | $-4.0M | ||
| Q1 25 | $137.0M | $87.3M | ||
| Q4 24 | $31.0M | $77.7M | ||
| Q3 24 | $122.0M | $83.1M | ||
| Q2 24 | $89.0M | $99.7M |
| Q1 26 | 54.7% | — | ||
| Q4 25 | 51.4% | 29.8% | ||
| Q3 25 | 54.2% | 30.4% | ||
| Q2 25 | 54.4% | 30.6% | ||
| Q1 25 | 53.8% | 30.0% | ||
| Q4 24 | 53.9% | 30.2% | ||
| Q3 24 | 56.0% | 29.6% | ||
| Q2 24 | 54.6% | 30.8% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 6.3% | 11.2% | ||
| Q3 25 | 80.6% | 13.5% | ||
| Q2 25 | 9.9% | 2.8% | ||
| Q1 25 | 7.3% | 13.2% | ||
| Q4 24 | 6.6% | 11.6% | ||
| Q3 24 | 13.2% | 12.3% | ||
| Q2 24 | 11.7% | 14.2% |
| Q1 26 | 0.6% | — | ||
| Q4 25 | 3.2% | 16.2% | ||
| Q3 25 | 60.4% | 9.5% | ||
| Q2 25 | 4.2% | -0.4% | ||
| Q1 25 | 6.6% | 9.0% | ||
| Q4 24 | 1.5% | 7.5% | ||
| Q3 24 | 5.9% | 8.1% | ||
| Q2 24 | 4.3% | 9.6% |
| Q1 26 | $0.07 | — | ||
| Q4 25 | $0.37 | $9.02 | ||
| Q3 25 | $7.22 | $4.98 | ||
| Q2 25 | $0.51 | $-1.53 | ||
| Q1 25 | $0.78 | $4.32 | ||
| Q4 24 | $0.18 | $3.85 | ||
| Q3 24 | $0.70 | $4.11 | ||
| Q2 24 | $0.51 | $4.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $561.0M | $187.1M |
| Total DebtLower is stronger | $4.6B | $795.7M |
| Stockholders' EquityBook value | $5.0B | $1.6B |
| Total Assets | $14.1B | $3.4B |
| Debt / EquityLower = less leverage | 0.92× | 0.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $561.0M | — | ||
| Q4 25 | $878.0M | $187.1M | ||
| Q3 25 | $1.6B | $226.1M | ||
| Q2 25 | $492.0M | $208.5M | ||
| Q1 25 | $534.0M | $184.4M | ||
| Q4 24 | $762.0M | $164.3M | ||
| Q3 24 | $772.0M | $200.5M | ||
| Q2 24 | $897.0M | $163.1M |
| Q1 26 | $4.6B | — | ||
| Q4 25 | $5.0B | $795.7M | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $7.8B | — | ||
| Q1 25 | $7.9B | — | ||
| Q4 24 | $8.0B | $730.6M | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.3B | — |
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $1.6B | ||
| Q3 25 | $5.0B | $1.6B | ||
| Q2 25 | $3.6B | $1.5B | ||
| Q1 25 | $3.3B | $1.6B | ||
| Q4 24 | $3.0B | $1.5B | ||
| Q3 24 | $3.2B | $1.5B | ||
| Q2 24 | $2.9B | $1.5B |
| Q1 26 | $14.1B | — | ||
| Q4 25 | $14.3B | $3.4B | ||
| Q3 25 | $14.0B | $3.4B | ||
| Q2 25 | $15.1B | $3.3B | ||
| Q1 25 | $14.5B | $3.4B | ||
| Q4 24 | $14.5B | $3.3B | ||
| Q3 24 | $14.7B | $3.5B | ||
| Q2 24 | $14.6B | $3.5B |
| Q1 26 | 0.92× | — | ||
| Q4 25 | 1.00× | 0.49× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.14× | — | ||
| Q1 25 | 2.43× | — | ||
| Q4 24 | 2.71× | 0.47× | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 2.90× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $111.2M |
| Free Cash FlowOCF − Capex | $-273.0M | $70.4M |
| FCF MarginFCF / Revenue | -13.6% | 6.8% |
| Capex IntensityCapex / Revenue | — | 3.9% |
| Cash ConversionOCF / Net Profit | — | 0.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-203.0M | $311.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $95.0M | $111.2M | ||
| Q3 25 | $76.0M | $112.5M | ||
| Q2 25 | $169.0M | $167.6M | ||
| Q1 25 | $29.0M | $65.1M | ||
| Q4 24 | $219.0M | $193.4M | ||
| Q3 24 | $169.0M | $225.1M | ||
| Q2 24 | $355.0M | $130.8M |
| Q1 26 | $-273.0M | — | ||
| Q4 25 | $32.0M | $70.4M | ||
| Q3 25 | $-21.0M | $70.6M | ||
| Q2 25 | $59.0M | $135.6M | ||
| Q1 25 | $-80.0M | $34.8M | ||
| Q4 24 | $92.0M | $167.8M | ||
| Q3 24 | $76.0M | $204.6M | ||
| Q2 24 | $297.0M | $112.5M |
| Q1 26 | -13.6% | — | ||
| Q4 25 | 1.6% | 6.8% | ||
| Q3 25 | -1.0% | 6.7% | ||
| Q2 25 | 2.7% | 12.9% | ||
| Q1 25 | -3.9% | 3.6% | ||
| Q4 24 | 4.4% | 16.2% | ||
| Q3 24 | 3.7% | 20.1% | ||
| Q2 24 | 14.3% | 10.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 3.9% | ||
| Q3 25 | 4.6% | 4.0% | ||
| Q2 25 | 5.1% | 3.0% | ||
| Q1 25 | 5.3% | 3.1% | ||
| Q4 24 | 6.1% | 2.5% | ||
| Q3 24 | 4.5% | 2.0% | ||
| Q2 24 | 2.8% | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.51× | 0.66× | ||
| Q3 25 | 0.06× | 1.14× | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 0.21× | 0.75× | ||
| Q4 24 | 7.06× | 2.49× | ||
| Q3 24 | 1.39× | 2.71× | ||
| Q2 24 | 3.99× | 1.31× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SOLV
| Infection Prevention and Surgical Solutions | $737.0M | 37% |
| Advanced Wound Care | $497.0M | 25% |
| Dental Solutions | $354.0M | 18% |
| Health Information Systems | $342.0M | 17% |
| All Other 4 | $76.0M | 4% |
VMI
| Utility Product Line | $424.5M | 41% |
| Lighting And Transportation | $204.6M | 20% |
| Irrigation Equipment And Parts Excluding Technology | $199.0M | 19% |
| Services | $113.6M | 11% |
| Telecommunications | $73.8M | 7% |
| Technology Products And Services | $23.7M | 2% |
